vikram deshpande
vikram deshpande
Professor of Pathology, Harvard Medical School
Verified email at partners.org
Title
Cited by
Cited by
Year
IgG4-related disease
JH Stone, Y Zen, V Deshpande
New England Journal of Medicine 366 (6), 539-551, 2012
24262012
Consensus statement on the pathology of IgG4-related disease
V Deshpande, Y Zen, JKC Chan, EY Eunhee, Y Sato, T Yoshino, ...
Modern Pathology 25 (9), 1181-1192, 2012
20652012
IgG4-related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations
JH Stone, A Khosroshahi, V Deshpande, JKC Chan, JG Heathcote, ...
Arthritis and rheumatism 64 (10), 3061, 2012
7062012
Frequent mutation of isocitrate dehydrogenase (IDH) 1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
DR Borger, KK Tanabe, KC Fan, HU Lopez, VR Fantin, KS Straley, ...
The oncologist 17 (1), 72, 2012
6382012
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer
CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ...
Annals of surgery 261 (1), 12, 2015
5922015
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease
A Khosroshahi, DB Bloch, V Deshpande, JH Stone
Arthritis & Rheumatism 62 (6), 1755-1762, 2010
5882010
Autoimmune pancreatitis
DL Finkelberg, D Sahani, V Deshpande, WR Brugge
New England Journal of Medicine 355 (25), 2670-2676, 2006
5812006
mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
ÖH Yilmaz, P Katajisto, DW Lamming, Y Gültekin, KE Bauer-Rowe, ...
Nature 486 (7404), 490-495, 2012
5582012
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients
A Khosroshahi, MN Carruthers, V Deshpande, S Unizony, DB Bloch, ...
Medicine 91 (1), 57-66, 2012
5382012
Rituximab for IgG4-related disease: a prospective, open-label trial
MN Carruthers, MD Topazian, A Khosroshahi, TE Witzig, ZS Wallace, ...
Annals of the rheumatic diseases 74 (6), 1171-1177, 2015
5142015
Genome-wide chromatin state transitions associated with developmental and environmental cues
J Zhu, M Adli, JY Zou, G Verstappen, M Coyne, X Zhang, T Durham, ...
Cell 152 (3), 642-654, 2013
5132013
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
RM Perera, S Stoykova, BN Nicolay, KN Ross, J Fitamant, M Boukhali, ...
Nature 524 (7565), 361-365, 2015
5032015
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers
DT Ting, D Lipson, S Paul, BW Brannigan, S Akhavanfard, EJ Coffman, ...
science 331 (6017), 593-596, 2011
4412011
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
MN Carruthers, A Khosroshahi, T Augustin, V Deshpande, JH Stone
Annals of the rheumatic diseases 74 (1), 14-18, 2015
4372015
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
S Beyaz, MD Mana, J Roper, D Kedrin, A Saadatpour, SJ Hong, ...
Nature 531 (7592), 53-58, 2016
4312016
IgG4‐related disease: clinical and laboratory features in one hundred twenty‐five patients
ZS Wallace, V Deshpande, H Mattoo, VS Mahajan, M Kulikova, S Pillai, ...
Arthritis & rheumatology 67 (9), 2466-2475, 2015
4182015
Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus
W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ...
PLoS genetics 6 (2), e1000841, 2010
4102010
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
ZS Wallace, H Mattoo, M Carruthers, VS Mahajan, E Della Torre, H Lee, ...
Annals of the rheumatic diseases 74 (1), 190-195, 2015
4042015
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set
DS Klimstra, IR Modlin, NV Adsay, R Chetty, V Deshpande, M Gönen, ...
The American journal of surgical pathology 34 (3), 300-313, 2010
4002010
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection?
IT Konstantinidis, AL Warshaw, JN Allen, LS Blaszkowsky, ...
Annals of surgery 257 (4), 731-736, 2013
3862013
The system can't perform the operation now. Try again later.
Articles 1–20